Left Atrial Structure and Function Following Ethanol Infusion into Vein of Marshall (MR‐SHALL Study)
Julia Aranyó,Gladys Juncà,Axel Sarrias,Victor Bazan,Daniel Cea,Roger Villuendas,Carolina Gálvez‐Montón,Eduard Fernandez‐Nofrerias,Antoni Bayes‐Genís,Victoria Delgado,Albert Teis,Felipe Bisbal
DOI: https://doi.org/10.1111/jce.16491
IF: 2.7
2024-11-10
Journal of Cardiovascular Electrophysiology
Abstract:We analyzed scar formation following ethanol infusion into the vein of Marshall (EI‐VOM), and its impact on left atrium (LA) function. EI‐VOM produced persistent scarring detected by LGE‐CMR at the 3‐month follow‐up. LGE‐CMR scarring involved the whole VOM trajectory. LA volume was reduced after ablation, without significant changes in LA functional parameters. Background Ethanol infusion into the vein of Marshall (EI‐VOM) is an adjunctive therapy to pulmonary vein isolation (PVI), which improves the efficacy of persistent atrial fibrillation (AF) ablation procedures. It is unknown how EI‐VOM scar formation impacts left atrium (LA) structure and function. Objective To characterize scar formation after EI‐VOM, and its impact on LA function, by cardiac magnetic resonance (CMR). Methods Consecutive patients referred for persistent AF ablation, or any repeat procedure, were included. Ablation strategy included PVI, EI‐VOM and linear lesions when deemed necessary. LA was assessed by late gadolinium enhancement (LGE) CMR at baseline and 3‐month follow‐up. CMR was post‐processed off‐line with dedicated software. The LA was regionalized into 17 segments, and global and regional scarring were calculated. Strain parameters were analyzed—including LA reservoir, conduit, and booster strain; LA ejection fraction; and LA passive and active emptying function. Follow‐up LGE‐CMR reconstruction was coregistered with the voltage map, ablation RF points, and fluoroscopy to compare the scar location with the VOM trajectory. Results This study included 21 patients (65 ± 8 years; 76% men; 57% ablation of persistent AF). After EI‐VOM, 95% of patients presented new low‐voltage areas, all of whom exhibited new LGE‐CMR scarring at follow‐up. Voltage map and LGE‐CMR coregistration showed comparable scar areas (p = 0.287). LGE‐CMR scarring frequently involved the whole VOM trajectory, predominantly affecting the LA ridge, mitral isthmus, and left posterior wall. LA volume was significantly reduced after ablation, without significant changes in LA functional parameters. Conclusion EI‐VOM causes permanent scarring at 3‐month follow‐up, with no adverse impact on CMR LA functional parameters.
cardiac & cardiovascular systems